SGE Consulting is delighted to have co-authored a Budget Impact Analysis on the introduction of #IMPELLA® technologies in France.
From the French National Health Systems’ perspective, the adoption of the Mechanical Circulatory Supports, Impella® 5.0 and Impella® CP, would produce savings over 5 years compared with the scenario without MCSs. The results were published in the “ADVANCES IN THERAPY” journal for Impella® CP (Jan 2022 issue).
You can also look up the Impella® 5.0 publication in the “CLINICOECONOMICS AND OUTCOMES RESEARCH” journal.
The manuscripts are available in Open Access, just click the links below.